Ascomycin
CAS No. 104987-12-4
Ascomycin ( FK-520; FR900520; L-683590; Changchuanmycin )
产品货号. M17780 CAS No. 104987-12-4
Ascomycin(Immunomycin, FR-900520, FK520) is an ethyl analog of tacrolimus (FK506) with strong immunosuppressant properties.
纯度: 98%
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
规格 | 价格/人民币 | 库存 | 数量 |
5MG | ¥292 | 有现货 |
|
10MG | ¥421 | 有现货 |
|
50MG | ¥510 | 有现货 |
|
100MG | ¥656 | 有现货 |
|
200MG | 获取报价 | 有现货 |
|
500MG | 获取报价 | 有现货 |
|
1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Ascomycin
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述Ascomycin(Immunomycin, FR-900520, FK520) is an ethyl analog of tacrolimus (FK506) with strong immunosuppressant properties.
-
产品描述Ascomycin, also known as KF-520, FR900520, L 683590, produced by the fermentation of S. hygroscopicus subsp. ascomyceticus, is an ethyl analog of tacrolimus (FK-506) with potent immunosuppressant properties.
-
同义词FK-520; FR900520; L-683590; Changchuanmycin
-
通路Others
-
靶点Other Targets
-
受体calcineurin phosphatase
-
研究领域Infection
-
适应症——
化学信息
-
CAS Number104987-12-4
-
分子量792.01
-
分子式C43H69NO12
-
纯度98%
-
溶解度DMSO : ≥ 39 mg/mL; 49.24 mM
-
SMILESO1[C@@]2(O)C(=O)C(=O)N3[C@H](C(=O)O[C@@H]([C@@H]([C@@H](O)CC(=O)[C@@H](/C=C(/C[C@@H](C[C@H](OC)[C@@H]1[C@@H](OC)C[C@H]2C)C)\C)CC)C)/C(=C/[C@H]1C[C@@H](OC)[C@H](O)CC1)/C)CCCC3
-
化学全称(3S,4R,5S,8R,9E,12S,14S,15R,16S,18R,19R,26aS)-8-ethyl-5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-hexadecahydro-5,19-dihydroxy-3-[(1E)-2-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]-1-methylethenyl]-14,16-dimethoxy-4,10,12,18-tetramethyl-15,19-epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclotricosine-1,7,20,21(4H,23H)-tetrone
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Hatanaka H, et al. J Antibiot (Tokyo). 1988, 41(11), 1592-1601.
产品手册
关联产品
-
2-O-acetylsaikosapon...
2''-O-acetylsaikosaponin A is a natural product for research related to life sciences.
-
Aspoxicillin
Aspoxicillin is a broad-spectrum antimicrobial agent against Actinobacillus pleuropneumoniae with of MIC90 < or = 0.05 μg/ml.
-
Chamigrenol
Chamigrenol is a promising candidate for the development of potent Na+/K+ ATPase inhibitors and antimicrobial agents.